<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02293629</url>
  </required_header>
  <id_info>
    <org_study_id>IM008-003</org_study_id>
    <nct_id>NCT02293629</nct_id>
  </id_info>
  <brief_title>A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects</brief_title>
  <official_title>A Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bristol-Myers Squibb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is the first clinical study with the BMS-986147 compound in healthy subjects. The
      purpose of this study is to guide the dose range and dose frequency for future studies with
      BMS-986147 and will provide guidelines for selection of a potentially effective dose in
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety and tolerability of single oral dose of BMS-986147 based on incidence of AEs, serious AEs, AEs leading to discontinuation, and death as well as marked abnormalities in clinical laboratory tests, vital sign measurements, and physical examinations</measure>
    <time_frame>Up to 30 days post last dose of study drug</time_frame>
    <description>Adverse event (AE)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety and tolerability of multiple oral dose of BMS-986147 based on incidence of AEs, serious AEs, AEs leading to discontinuation, and death as well as marked abnormalities in clinical laboratory tests, vital sign measurements, and physical examinations</measure>
    <time_frame>Up to 30 days post last dose of study drug</time_frame>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>A1: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single oral dose as specified</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single oral dose as specified</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A3: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single oral dose as specified</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B1: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily oral dose as specified</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B2: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily oral dose as specified</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BMS-986147</intervention_name>
    <arm_group_label>A1: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_label>A2: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_label>A3: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_label>B1: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_label>B2: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo matching BMS-986147</intervention_name>
    <arm_group_label>A1: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_label>A2: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_label>A3: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_label>B1: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
    <arm_group_label>B2: BMS-986147 or Placebo matching BMS-986147</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For more information regarding BMS clinical trial participation, please visit
        www.BMSStudyConnect.com

        Inclusion Criteria:

          -  Healthy men and women, ages 18 to 45 years

          -  Subjects must not have clinically significant deviation from normal: medical history,
             physical examination, ECGs and laboratory evaluations

          -  Women of child bearing potential are eligible for enrollment.

          -  Women must have a negative pregnancy test

        Exclusion Criteria:

          -  Evidence of organ dysfunction

          -  Any significant acute or chronic medical illness

          -  Inability to: tolerate oral medications, be venipunctured
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bristol-Myers Squibb</last_name>
    <role>Study Director</role>
    <affiliation>Bristol-Myers Squibb</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wcct Global, Llc</name>
      <address>
        <city>Cypress</city>
        <state>California</state>
        <zip>90630</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.bms.com/studyconnect/Pages/home.aspx</url>
    <description>BMS clinical trial educational resource</description>
  </link>
  <link>
    <url>http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx</url>
    <description>Investigator Inquiry form</description>
  </link>
  <link>
    <url>http://www.fda.gov/MEDWATCH/safety.htm</url>
    <description>FDA Safety Alerts and Recalls</description>
  </link>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2014</study_first_submitted>
  <study_first_submitted_qc>November 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2014</study_first_posted>
  <last_update_submitted>May 18, 2015</last_update_submitted>
  <last_update_submitted_qc>May 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

